Caxton Associates (New York)’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,150
| Closed | -$243K | – | 487 |
|
|
2024
Q3 | $243K | Buy |
+29,150
| New | +$243K | 0.01% | 463 |
|
|
2024
Q2 | – | Sell |
-91,481
| Closed | -$554K | – | 467 |
|
|
2024
Q1 | $554K | Buy |
91,481
+8,088
| +10% | +$49K | 0.03% | 304 |
|
|
2023
Q4 | $506K | Sell |
83,393
-36,887
| -31% | -$224K | 0.03% | 320 |
|
|
2023
Q3 | $508K | Buy |
+120,280
| New | +$508K | 0.07% | 237 |
|